13.16

2.66% -0.36

After Hours: 13.50 0.34 +2.58%

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $13.16, with a volume of 1.27M. It is down -2.66% in the last 24 hours and up +31.47% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$13.52

Open:

$13.99

24h Volume:

1.27M

Relative Volume:

0.76

Market Cap:

$619.70M

Revenue:

$217.11M

Net Income/Loss:

$-651.19M

P/E Ratio:

-1.0131

EPS:

-12.99

Net Cash Flow:

$-387.26M

1W Performance:

-11.50%

1M Performance:

+31.47%

6M Performance:

+62.07%

1Y Performance:

+79.54%

1-Day Range:

$13.15

$14.10

1-Week Range:

$13.15

$17.58

52-Week Range:

$5.00

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

834

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	13.16	800.38M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

11:24 AM

How Ginkgo Bioworks Holdings Inc. Class stock behaves in tightening cyclesExit Point & Reliable Price Breakout Alerts - newser.com

11:24 AM

11:01 AM

Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com

11:01 AM

10:59 AM

How sentiment analysis helps forecast Ginkgo Bioworks Holdings Inc.2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com

10:59 AM

09:53 AM

Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.Buy Signal & Growth Oriented Trade Recommendations - newser.com

09:53 AM

08:46 AM

Advanced analytics toolkit walkthrough for Ginkgo Bioworks Holdings Inc.Earnings Recap Report & Free High Return Stock Watch Alerts - newser.com

08:46 AM

Oct 12, 2025

Ginkgo Bioworks Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 12, 2025

Has Ginkgo Bioworks Holdings Inc. found a price floorGlobal Markets & Consistent Profit Trading Strategies - newser.com

Oct 12, 2025

Oct 10, 2025

Ginkgo Bioworks (NYSE:DNA) Sets New 12-Month HighTime to Buy? - MarketBeat

Oct 10, 2025

Will Ginkgo Bioworks Holdings Inc. Class stock benefit from sector leadershipJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com

Oct 10, 2025

Can Ginkgo Bioworks Holdings Inc. stock outperform in 2025 bull market2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com

Oct 10, 2025

Custom watchlist performance reports with Ginkgo Bioworks Holdings Inc.July 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com

Oct 10, 2025

Looking at the Narrative for Ginkgo Bioworks After Recent Analyst and Strategy Updates - Yahoo Finance

Oct 10, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Ginkgo Bioworks (NYSE:DNA) - MarketBeat

Oct 10, 2025

Oct 09, 2025